Literature DB >> 9216991

A nonsense mutation in the alpha4 subunit of the nicotinic acetylcholine receptor (CHRNA4) cosegregates with 20q-linked benign neonatal familial convulsions (EBNI)

C Beck1, B Moulard, O Steinlein, M Guipponi, L Vallee, P Montpied, M Baldy-Moulnier, A Malafosse.   

Abstract

Benign Familial Neonatal Convulsions (BFNC) is an epileptic disorder with an autosomal dominant mode of transmission. It has been shown that about 80% of BFNC pedigrees are linked to a genetic defect on chromosome 20q13.3. A candidate gene for the epilepsies, the gene coding for the alpha4 subunit of the nicotinic cholinergic receptor (CHRNA4), has previously been localized on chromosome 20. Here we report a single point mutation converting a serine codon to a stop codon in the exon 5 of CHRNA4, in one BFNC family. Identification of CHRNA4 as the defective gene in 20q-BFNC represents the first example of a human idiopathic epilepsy caused by a mutation directly affecting a neurotransmitter receptor in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 9216991     DOI: 10.1006/nbdi.1994.0012

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  8 in total

1.  Co-expression of the neuronal alpha7 and L247T alpha7 mutant subunits yields hybrid nicotinic receptors with properties of both wild-type alpha7 and alpha7 mutant homomeric receptors.

Authors:  E Palma; F Eusebi; R Miledi
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

2.  Genetic and physical mapping of the progressive epilepsy with mental retardation (EPMR) locus on chromosome 8p.

Authors:  S Ranta; A E Lehesjoki; A Hirvasniemi; J Weissenbach; B Ross; S M Leal; A de la Chapelle; T C Gilliam
Journal:  Genome Res       Date:  1996-05       Impact factor: 9.043

Review 3.  The relevance of inter- and intrastrain differences in mice and rats and their implications for models of seizures and epilepsy.

Authors:  Wolfgang Löscher; Russell J Ferland; Thomas N Ferraro
Journal:  Epilepsy Behav       Date:  2017-06-23       Impact factor: 2.937

4.  Human alpha4beta2 neuronal nicotinic acetylcholine receptor in HEK 293 cells: A patch-clamp study.

Authors:  B Buisson; M Gopalakrishnan; S P Arneric; J P Sullivan; D Bertrand
Journal:  J Neurosci       Date:  1996-12-15       Impact factor: 6.167

Review 5.  A roadmap for precision medicine in the epilepsies.

Authors: 
Journal:  Lancet Neurol       Date:  2015-09-20       Impact factor: 44.182

6.  Exome sequencing identifies molecular diagnosis in children with drug-resistant epilepsy.

Authors:  Mandy Ho-Yin Tsang; Gordon Ka-Chun Leung; Alvin Chi-Chung Ho; Kit-San Yeung; Christopher Chun-Yu Mak; Steven Lim-Cho Pei; Mullin Ho-Chung Yu; Anita Sik-Yau Kan; Kelvin Yuen-Kwong Chan; Karen Ling Kwong; So-Lun Lee; Ada Wing-Yan Yung; Cheuk-Wing Fung; Brian Hon-Yin Chung
Journal:  Epilepsia Open       Date:  2018-12-06

7.  Assessment of burden and segregation profiles of CNVs in patients with epilepsy.

Authors:  Claudia Moreau; Frédérique Tremblay; Stefan Wolking; Alexandre Girard; Catherine Laprise; Fadi F Hamdan; Jacques L Michaud; Berge A Minassian; Patrick Cossette; Simon L Girard
Journal:  Ann Clin Transl Neurol       Date:  2022-06-08       Impact factor: 5.430

8.  Pathogenic EFHC1 mutations are tolerated in healthy individuals dependent on reported ancestry.

Authors:  Ryan L Subaran; Juliette M Conte; William C L Stewart; David A Greenberg
Journal:  Epilepsia       Date:  2014-12-08       Impact factor: 5.864

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.